Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiotherapy Planning, Computer-Assisted | 22 | 2023 | 1622 | 1.920 |
Why?
|
Protons | 16 | 2023 | 1126 | 1.910 |
Why?
|
Radiotherapy, Conformal | 5 | 2021 | 548 | 1.130 |
Why?
|
Radiotherapy Dosage | 21 | 2022 | 2876 | 1.030 |
Why?
|
Monte Carlo Method | 8 | 2022 | 1254 | 0.950 |
Why?
|
Radiotherapy, Intensity-Modulated | 6 | 2021 | 806 | 0.900 |
Why?
|
Titanium | 1 | 2023 | 494 | 0.720 |
Why?
|
Phantoms, Imaging | 7 | 2023 | 2466 | 0.540 |
Why?
|
Photons | 4 | 2017 | 587 | 0.520 |
Why?
|
Postoperative Care | 3 | 2018 | 1484 | 0.510 |
Why?
|
Mastectomy | 5 | 2021 | 1789 | 0.490 |
Why?
|
Radiography | 3 | 2013 | 7010 | 0.400 |
Why?
|
Organs at Risk | 5 | 2021 | 346 | 0.400 |
Why?
|
Radiometry | 4 | 2023 | 800 | 0.390 |
Why?
|
Radiotherapy, High-Energy | 1 | 2011 | 228 | 0.370 |
Why?
|
Chordoma | 3 | 2023 | 359 | 0.370 |
Why?
|
Semiconductors | 1 | 2011 | 105 | 0.360 |
Why?
|
Oxides | 1 | 2011 | 405 | 0.340 |
Why?
|
Breast Neoplasms | 7 | 2021 | 20774 | 0.290 |
Why?
|
Metals | 1 | 2011 | 717 | 0.280 |
Why?
|
Lung | 4 | 2021 | 9826 | 0.220 |
Why?
|
Scattering, Radiation | 3 | 2017 | 498 | 0.210 |
Why?
|
Calibration | 2 | 2022 | 815 | 0.200 |
Why?
|
Liver | 2 | 2022 | 7470 | 0.170 |
Why?
|
Skull Base Neoplasms | 1 | 2023 | 284 | 0.170 |
Why?
|
Radiation Dosage | 3 | 2018 | 1927 | 0.170 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2018 | 1769 | 0.160 |
Why?
|
Patient Positioning | 2 | 2018 | 322 | 0.160 |
Why?
|
Spinal Neoplasms | 2 | 2014 | 759 | 0.150 |
Why?
|
Microtechnology | 1 | 2017 | 72 | 0.150 |
Why?
|
Prostatic Neoplasms | 2 | 2019 | 11039 | 0.150 |
Why?
|
Relative Biological Effectiveness | 5 | 2021 | 323 | 0.140 |
Why?
|
Uncertainty | 2 | 2019 | 725 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 6 | 2023 | 20086 | 0.130 |
Why?
|
Tumor Burden | 3 | 2021 | 1905 | 0.130 |
Why?
|
Heart | 2 | 2021 | 4462 | 0.130 |
Why?
|
Carotid Stenosis | 1 | 2023 | 854 | 0.130 |
Why?
|
Misonidazole | 1 | 2014 | 34 | 0.130 |
Why?
|
Algorithms | 6 | 2022 | 13853 | 0.130 |
Why?
|
Breast Implants | 1 | 2018 | 378 | 0.120 |
Why?
|
Artifacts | 1 | 2023 | 1903 | 0.120 |
Why?
|
Thoracic Wall | 1 | 2016 | 201 | 0.120 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2019 | 475 | 0.110 |
Why?
|
Radiation Injuries | 2 | 2021 | 1178 | 0.110 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2013 | 140 | 0.110 |
Why?
|
Pituitary Neoplasms | 1 | 2021 | 1340 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1052 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2014 | 675 | 0.100 |
Why?
|
Fiducial Markers | 1 | 2013 | 136 | 0.100 |
Why?
|
Supratentorial Neoplasms | 1 | 2013 | 160 | 0.100 |
Why?
|
Mammaplasty | 1 | 2021 | 1195 | 0.100 |
Why?
|
Normal Distribution | 3 | 2019 | 280 | 0.100 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2712 | 0.100 |
Why?
|
Humans | 33 | 2023 | 742088 | 0.090 |
Why?
|
X-Rays | 1 | 2011 | 301 | 0.090 |
Why?
|
Liposarcoma, Myxoid | 1 | 2010 | 64 | 0.090 |
Why?
|
Gamma Rays | 1 | 2011 | 320 | 0.090 |
Why?
|
Carbon | 1 | 2013 | 686 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 1 | 2011 | 307 | 0.080 |
Why?
|
Cerebellar Neoplasms | 1 | 2013 | 585 | 0.080 |
Why?
|
Neoplasms | 2 | 2015 | 21596 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3465 | 0.080 |
Why?
|
Medulloblastoma | 1 | 2013 | 681 | 0.080 |
Why?
|
Spine | 1 | 2014 | 1143 | 0.070 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2010 | 334 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2017 | 3801 | 0.060 |
Why?
|
Radiotherapy | 1 | 2012 | 1525 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2658 | 0.060 |
Why?
|
Computer Simulation | 3 | 2012 | 6191 | 0.060 |
Why?
|
Sarcoma | 1 | 2014 | 1895 | 0.050 |
Why?
|
Female | 12 | 2022 | 379592 | 0.050 |
Why?
|
Contrast Media | 1 | 2014 | 5295 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 8829 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9963 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3507 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6259 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2014 | 13019 | 0.040 |
Why?
|
Skull | 1 | 2023 | 810 | 0.040 |
Why?
|
Craniopharyngioma | 1 | 2021 | 281 | 0.040 |
Why?
|
Moyamoya Disease | 1 | 2021 | 237 | 0.040 |
Why?
|
Nausea | 1 | 2021 | 665 | 0.040 |
Why?
|
Vomiting | 1 | 2021 | 632 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2021 | 62966 | 0.040 |
Why?
|
Male | 8 | 2022 | 349538 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9185 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 8925 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14720 | 0.030 |
Why?
|
Models, Statistical | 3 | 2019 | 5100 | 0.030 |
Why?
|
Breast Implantation | 1 | 2018 | 218 | 0.030 |
Why?
|
Sacrococcygeal Region | 1 | 2014 | 52 | 0.030 |
Why?
|
Lymphocytes | 1 | 2022 | 2614 | 0.030 |
Why?
|
Pelvic Neoplasms | 1 | 2015 | 254 | 0.030 |
Why?
|
Vision Disorders | 1 | 2021 | 1057 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1526 | 0.030 |
Why?
|
Probability | 1 | 2019 | 2502 | 0.030 |
Why?
|
Thoracic Neoplasms | 1 | 2015 | 268 | 0.030 |
Why?
|
Models, Biological | 1 | 2010 | 9581 | 0.030 |
Why?
|
Headache | 1 | 2021 | 1219 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35342 | 0.030 |
Why?
|
Sacrum | 1 | 2014 | 289 | 0.030 |
Why?
|
Chondrosarcoma | 1 | 2014 | 309 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2014 | 525 | 0.020 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 258 | 0.020 |
Why?
|
Ions | 1 | 2012 | 264 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 2013 | 248 | 0.020 |
Why?
|
Linear Energy Transfer | 1 | 2012 | 154 | 0.020 |
Why?
|
Cranial Irradiation | 1 | 2013 | 401 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2012 | 876 | 0.020 |
Why?
|
Middle Aged | 5 | 2019 | 213127 | 0.020 |
Why?
|
Technology, Radiologic | 1 | 2010 | 163 | 0.020 |
Why?
|
Thoracic Vertebrae | 1 | 2014 | 604 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2016 | 1265 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 56350 | 0.020 |
Why?
|
Child | 3 | 2023 | 77478 | 0.020 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.020 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2013 | 770 | 0.020 |
Why?
|
Body Height | 1 | 2013 | 1574 | 0.020 |
Why?
|
Infant | 2 | 2021 | 35070 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 77098 | 0.020 |
Why?
|
Cell Communication | 1 | 2012 | 1619 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 40955 | 0.020 |
Why?
|
Aged | 4 | 2020 | 162944 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2014 | 5062 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2013 | 3471 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2014 | 1844 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19862 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6534 | 0.010 |
Why?
|
Cause of Death | 1 | 2013 | 3571 | 0.010 |
Why?
|
Time Factors | 2 | 2018 | 40054 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5872 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8297 | 0.010 |
Why?
|
Prospective Studies | 2 | 2014 | 53187 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 85649 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12773 | 0.010 |
Why?
|
Adult | 3 | 2019 | 213712 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16665 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39004 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 57683 | 0.010 |
Why?
|
Brain | 1 | 2012 | 26343 | 0.000 |
Why?
|
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_